FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895827580> ?p ?o ?g. }

• W2895827580 endingPage "135" @default.
• W2895827580 startingPage "125" @default.
• W2895827580 abstract "Endogenous biomarkers can be clinically relevant tools for the assessment of transporter function in vivo and corresponding drug-drug interactions (DDIs). The aim of this study was to perform systematic evaluation of plasma data obtained for 20 endogenous molecules in the same healthy subjects (n = 8-12) in the absence and presence of organic anion transporting polypeptide (OATP) inhibitor rifampicin (600 mg, single dose). The extent of rifampicin DDI magnitude [the ratio of the plasma concentration-time area under the curve (AUCR)], estimated fraction transported (fT), and baseline variability was compared across the biomarkers and relative to rosuvastatin and coproporphyrin I (CPI). Out of the 20 biomarkers investigated tetradecanedioate (TDA), hexadecanedioate (HDA), glycocholic acid, glycodeoxycholic acid (GDCA), taurodeoxycholic acid (TDCA), and coproporphyrin III (CPIII) showed the high AUCR (2.1-8.5) and fT (0.5-0.76) values, indicative of substantial OATP1B-mediated transport. A significant positive correlation was observed between the individual GDCA and TDCA AUCRs and the magnitude of rosuvastatin-rifampicin interaction. The CPI and CPIII AUCRs were significantly correlated, but no clear trend was established with the rosuvastatin AUCR. Moderate interindividual variability (15%-62%) in baseline exposure and AUCR was observed for TDA, HDA, and CPIII. In contrast, bile acids demonstrated high interindividual variability (69%-113%) and significant decreases in baseline plasma concentrations during the first 4 hours. This comprehensive analysis in the same individuals confirms that none of the biomarkers supersede CPI in the evaluation of OATP1B-mediated DDI risk. Monitoring of CPI and GDCA/TDCA may be beneficial for dual OATP1B/sodium-taurocholate cotransporting polypeptide inhibitors with consideration of challenges associated with large inter- and intraindividual variability observed for bile acids. Benefit of monitoring combined biomarkers (CPI, one bile acid and one fatty acid) needs to be confirmed with larger data sets and against multiple OATP1B clinical probes and perpetrators." @default.
• W2895827580 created "2018-10-26" @default.
• W2895827580 creator A5006075771 @default.
• W2895827580 creator A5011240907 @default.
• W2895827580 creator A5039851568 @default.
• W2895827580 creator A5059236152 @default.
• W2895827580 creator A5076919232 @default.
• W2895827580 creator A5080761940 @default.
• W2895827580 date "2018-10-12" @default.
• W2895827580 modified "2023-10-17" @default.
• W2895827580 title "Comprehensive Evaluation of the Utility of 20 Endogenous Molecules as Biomarkers of OATP1B Inhibition Compared with Rosuvastatin and Coproporphyrin I" @default.
• W2895827580 cites W1514132913 @default.
• W2895827580 cites W1583331540 @default.
• W2895827580 cites W1906327586 @default.
• W2895827580 cites W2002121467 @default.
• W2895827580 cites W2020757292 @default.
• W2895827580 cites W2031067362 @default.
• W2895827580 cites W2060231414 @default.
• W2895827580 cites W2077656434 @default.
• W2895827580 cites W2079197876 @default.
• W2895827580 cites W2131983256 @default.
• W2895827580 cites W2139413142 @default.
• W2895827580 cites W2172273796 @default.
• W2895827580 cites W2173726756 @default.
• W2895827580 cites W2337728755 @default.
• W2895827580 cites W2414860527 @default.
• W2895827580 cites W2483767994 @default.
• W2895827580 cites W2490529593 @default.
• W2895827580 cites W2502300957 @default.
• W2895827580 cites W2592427646 @default.
• W2895827580 cites W2598406479 @default.
• W2895827580 cites W2605233147 @default.
• W2895827580 cites W2605527602 @default.
• W2895827580 cites W2607318379 @default.
• W2895827580 cites W2616878580 @default.
• W2895827580 cites W2617224210 @default.
• W2895827580 cites W2619811860 @default.
• W2895827580 cites W2621394929 @default.
• W2895827580 cites W2773502951 @default.
• W2895827580 cites W2788664869 @default.
• W2895827580 cites W2799486834 @default.
• W2895827580 cites W2800152531 @default.
• W2895827580 cites W2803524261 @default.
• W2895827580 cites W2803665263 @default.
• W2895827580 cites W2804552830 @default.
• W2895827580 cites W2808994107 @default.
• W2895827580 cites W2885748302 @default.
• W2895827580 cites W2896835015 @default.
• W2895827580 doi "https://doi.org/10.1124/jpet.118.253062" @default.
• W2895827580 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30314992" @default.
• W2895827580 hasPublicationYear "2018" @default.
• W2895827580 type Work @default.
• W2895827580 sameAs 2895827580 @default.
• W2895827580 citedByCount "31" @default.
• W2895827580 countsByYear W28958275802019 @default.
• W2895827580 countsByYear W28958275802020 @default.
• W2895827580 countsByYear W28958275802021 @default.
• W2895827580 countsByYear W28958275802022 @default.
• W2895827580 countsByYear W28958275802023 @default.
• W2895827580 crossrefType "journal-article" @default.
• W2895827580 hasAuthorship W2895827580A5006075771 @default.
• W2895827580 hasAuthorship W2895827580A5011240907 @default.
• W2895827580 hasAuthorship W2895827580A5039851568 @default.
• W2895827580 hasAuthorship W2895827580A5059236152 @default.
• W2895827580 hasAuthorship W2895827580A5076919232 @default.
• W2895827580 hasAuthorship W2895827580A5080761940 @default.
• W2895827580 hasBestOaLocation W28958275801 @default.
• W2895827580 hasConcept C126322002 @default.
• W2895827580 hasConcept C16613235 @default.
• W2895827580 hasConcept C185592680 @default.
• W2895827580 hasConcept C2778607973 @default.
• W2895827580 hasConcept C2780035454 @default.
• W2895827580 hasConcept C2780499067 @default.
• W2895827580 hasConcept C3020079912 @default.
• W2895827580 hasConcept C501593827 @default.
• W2895827580 hasConcept C55493867 @default.
• W2895827580 hasConcept C71924100 @default.
• W2895827580 hasConcept C98274493 @default.
• W2895827580 hasConceptScore W2895827580C126322002 @default.
• W2895827580 hasConceptScore W2895827580C16613235 @default.
• W2895827580 hasConceptScore W2895827580C185592680 @default.
• W2895827580 hasConceptScore W2895827580C2778607973 @default.
• W2895827580 hasConceptScore W2895827580C2780035454 @default.
• W2895827580 hasConceptScore W2895827580C2780499067 @default.
• W2895827580 hasConceptScore W2895827580C3020079912 @default.
• W2895827580 hasConceptScore W2895827580C501593827 @default.
• W2895827580 hasConceptScore W2895827580C55493867 @default.
• W2895827580 hasConceptScore W2895827580C71924100 @default.
• W2895827580 hasConceptScore W2895827580C98274493 @default.
• W2895827580 hasIssue "1" @default.
• W2895827580 hasLocation W28958275801 @default.
• W2895827580 hasLocation W28958275802 @default.
• W2895827580 hasLocation W28958275803 @default.
• W2895827580 hasOpenAccess W2895827580 @default.
• W2895827580 hasPrimaryLocation W28958275801 @default.
• W2895827580 hasRelatedWork W2079503439 @default.
• W2895827580 hasRelatedWork W2081013641 @default.
• W2895827580 hasRelatedWork W2110390656 @default.

• next